IRYS price fluctuates by 45.0% in 24 hours: Driven by surge in trading volume and active leveraged futures
Bitget Pulse2026/04/13 13:01Volatility Overview
In the past 24 hours, IRYS rebounded from a low of $0.02426 to a high of $0.03518 and is currently trading at $0.03143, marking a fluctuation amplitude of 45.0%. 24-hour trading volume surged significantly to around $22.76 million, an increase of 168.90% compared to the previous day. Spot trading volume is about $2.68 million, while futures trading volume reached as high as $29.23 million.
Brief Analysis of Causes for the Surge
- Surge in Trading Volume: 24-hour turnover reached $22.76 million, up 168.90%, reflecting increased market activity, which may amplify price volatility.
- Futures Dominance with Leverage: Futures trading volume reached $29.23 million, far exceeding spot, increasing the likelihood of high volatility.
- Social Signals: On April 12, an Instagram post titled “$IRYS Breakout Buy Alert” mentioned potential for a price rebound, possibly sparking short-term buying interest.
No official announcements or on-chain whale large-scale transaction reports at present.
Market View and Outlook
Market sentiment is short-term optimistic. According to Coingecko data, the price increased more than 20% in 24 hours, with traders watching for a rebound to higher levels. However, platforms such as TradingView cautioned about high volatility risks, forecasting likely consolidation in the short term. Mainstream predictions see the price at about $0.0286 by the end of 2026, but emphasize leverage risks.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Marvell Technology (MRVL.US) plummets after earnings: Beating forecasts is not enough—Wall Street thinks Google (GOOGL.US) orders are recognized too slowly
Although Marvell Technology's latest financial report and future revenue guidance both superficially exceeded market expectations, its stock price still plummeted in pre-market trading on Friday.

Gold prices could soar to $12,000 if US national debt keeps rising, says strategist
PURR stock hits record $14.15 as Hyperliquid revenue tops $718 million
From Lowering Blood Sugar and Weight Loss to Cardiovascular Protection! Mounjaro Achieves "Cardiometabolic Leap," Lilly (LLY.US) Opens GLP-1's Second Growth Curve
Eli Lilly's diabetes drug Mounjaro has received approval in the United States for reducing the risk of serious cardiovascular disease. The U.S. Food and Drug Administration has approved Mounjaro for lowering cardiovascular risk in adults with type 2 diabetes who have established heart disease.
